According to the company, the application is designed to enhance the clinical trial supply management processes, increase patient safety, and improve the chain of custody record for clinical supplies.
The app features built-in barcode scanning capabilities and manages tasks such as confirming correct treatment allocation, dispensing to patients, and processing of medicinal product returns.
The fourth generation of the service was announced in May 2015 at which time the company's corporate VP of eClinical Operations, Kevin Bishop, told us the randomization algorithms available within ClinPhone are designed to "ensure that cohorts and treatment allocations are appropriately balanced according to the statistical objective of the study protocol, and that, if required, the blind is maintained."
Earlier this month, Parexel also announced its plan to acquire The Medical Affairs Company (TMAC). Through the acquisition, the company gains new medical affairs outsourcing capabilities that it said will strengthen and expand its commercialization and market access offerings.